March 2017


    • 16 Mar 2017

      Three Harvard Experts Explain How Economics Can Shape Precision Medicines

      BOSTON—Many public and private efforts focus on research in precision medicine, the process by which genomic information and other characteristics of a patient’s disease are used to predict which treatments will be most effective. Scientific initiatives alone, however, will not deliver such medicines without strong incentives to bring them to market. An article to be published in Science on Friday, March 17, 2017, examines the unique economics of precision medicines in the United States and the factors that impact their development, pricing, and access. Read more.

    • 08 Mar 2017

      Two HBS Faculty Members Win Awards in Global Case Centre Competition

      BOSTON—Two members of the Harvard Business School (HBS) faculty, along with their research associates, have won awards in the 2017 Case Centre Competition. First presented in 1991, these annual awards, which the Financial Times has described as the “the business school Oscars,” aim to recognize worldwide excellence in case writing and raise the profile of the case method, the centerpiece of participant-centered, discussion-based learning. Read more.